New Oxygen (SY.US) Q1 revenue decreased by 6.6% year-on-year, and the medical beauty treatment business is expected to increase by up to 410% in Q2.

Zhitong Finance and Economics APP learned that New York Science and Technology (SY.US) released its first-quarter 2025 financial report before the market opened on May 16th, Eastern Time. The data showed that the company's Q1 revenue reached $40.97 million, a year-on-year decrease of 6.6%, exceeding market expectations by $800,000. Q1 diluted loss per share under US Generally Accepted Accounting Principles (GAAP) was $0.04, slightly better than the market's average expected loss of $0.05 per share.